All Stories

  1. Size-tailored nanoparticle-antibody conjugates benefit for Alzheimer's disease therapy
  2. Reagentless, Wash-Free Multiplexed Analysis of Plasma Biomarkers for Alzheimer’s Disease Diagnosis via an Antibody-Based Molecular Pendulum
  3. Machine Learning‐Enhanced Ultrasensitive Immuno‐CRISPR Array Facilitates Early Diagnosis of Alzheimer's Disease by Detecting Multiple Plasma Biomarkers
  4. Dendritic mesoporous silica nanoparticle–based nasal delivery carriers for passive immunotherapy of Alzheimer’s disease
  5. HAAC Ligation-Enabled Hierarchical Assembly: Deciphering the Synergy of α-Hydroxyl Aldehydes and 2-Aminooxazoles
  6. A colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay improves the accuracy of early diagnosis of Alzheimer's disease by simultaneously detecting Aβ42 oligomers and phosphorylated tau
  7. Ultrasensitive CRISPR-based biosensing platform for early diagnosis of Alzheimer's disease by simultaneous detection of plasma Aβ and hyperphosphorylated tau
  8. Mn3O4 nanozyme-based anti-inflammatory therapy modulates microglial phenotype by downregulating TLR4/NOX2 expression and further alleviates Alzheimer's disease pathology
  9. CRISPR-based ultrasensitive multiplexed array for the detection of multiple plasma biomarkers for early Alzheimer’s disease diagnosis
  10. Light-Triggered Graphene/Black Phosphorus Heterostructure FET Platform for Ultrasensitive Detection of Alzheimer’s Disease Biomarkers at the Zeptomole Level
  11. Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer’s disease
  12. Correction: Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
  13. Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer’s disease
  14. Aβ42 and ROS Dual-targeted Multifunctional Nanocomposite for Combination Therapy of Alzheimer’s Disease
  15. An In Situ Study on Nanozyme Performance to Optimize Nanozyme-Strip for Aβ Detection
  16. Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer’s disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay
  17. Colorimetric and surface-enhanced Raman scattering dual-mode magnetic immunosensor for ultrasensitive detection of blood phosphorylated tau in Alzheimer's disease
  18. Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
  19. Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
  20. Current trends in blood biomarker detection and imaging for Alzheimer’s disease
  21. Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid β peptides and their dynamic aggregation process
  22. Visualizing dynamic changes in PD-L1 expression in non-small cell lung carcinoma with radiolabeled recombinant human PD-1
  23. Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism
  24. Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay
  25. Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer’s disease
  26. Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
  27. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis
  28. Optical Tissue Clearing: Illuminating Brain Function and Dysfunction
  29. Diagnostic assays for COVID-19: a narrative review
  30. Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis
  31. Instrument-Free and Visual Detection of Salmonella Based on Magnetic Nanoparticles and an Antibody Probe Immunosensor
  32. In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
  33. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment
  34. Chelator‐Free Radiolabeling of Nanographene: Breaking the Stereotype of Chelation
  35. Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer
  36. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging
  37. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
  38. Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry
  39. In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
  40. HaloTag Technology: A Versatile Platform for Biomedical Applications
  41. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment
  42. PET of c-Met in Cancer with 64Cu-Labeled Hepatocyte Growth Factor
  43. Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging
  44. Nasopharyngeal Cancer-Specific Therapy Based on Fusion Peptide-Functionalized Lipid Nanoparticles
  45. Design and Applications of Bispecific Heterodimers: Molecular Imaging and beyond
  46. Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo
  47. mBeRFP, an Improved Large Stokes Shift Red Fluorescent Protein
  48. An 125I-labeled octavalent peptide fluorescent nanoprobe for tumor-homing imaging in vivo
  49. Tetrameric far‐red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo